SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc. ® is pleased to announce the commercial launch and availability of Gvoke VialDx™ (glucagon injection). Gvoke VialDx (glucagon ...
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commercial launch ...
Glucagon is indicated for the treatment of severe hypoglycemia in patients with diabetes mellitus and as a diagnostic aid for use during certain radiologic examinations. Lupin is introducing glucagon ...
Xeris Biopharma specializes in making injectable drugs more accessible and user-friendly, largely through its proprietary formulation technologies. Its core commercial products are Recorlev (used to ...
Revenue (GAAP) jumped 48.8% year over year to $71.5 million in Q2 2025, topping GAAP estimates by $7.1 million. Earnings per share (GAAP) of $(0.01) beat expectations and improved from $(0.10) GAAP in ...
A panel discussion highlighted promising advances in diabetes technology and medicine aimed at preventing and managing hypoglycemia. Real-world experiences illustrated the challenges that people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback